A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity-Reference-Cited by-同舟云学术

A Naturally Occurring GIP Receptor Variant Undergoes Enhanced Agonist-Induced Desensitization, Which Impairs GIP Control of Adipose Insulin Sensitivity

Published:2014-07-21 Issue:19 Volume:34 Page:3618-3629
ISSN:0270-7306
Container-title:Molecular and Cellular Biology
language:en
Short-container-title:Molecular and Cellular Biology

Author:

Mohammad S.,Patel R. T.,Bruno J.,Panhwar M. S.,Wen J.,McGraw T. E.

Publisher

American Society for Microbiology

Subject

Cell Biology,Molecular Biology

Reference69 articles.

1. Stimulation of insulin secretion by gastric inhibitory polypeptide in man;Dupre;J. Clin. Endocrinol. Metab.,1973

2. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects;Ross;Diabetes,1978

3. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects;Vilsboll;Regul. Pept.,2003

4. The biology of incretin hormones;Drucker;Cell Metab.,2006

5. Intestinal factors in the control of insulin secretion;McIntyre;J. Clin. Endocrinol. Metab.,1965

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AT-7687, a novel GIPR peptide antagonist, combined with a GLP-1 agonist, leads to enhanced weight loss and metabolic improvements in cynomolgus monkeys;Molecular Metabolism;2024-10

2. Incretin therapy in feline diabetes mellitus – A review of the current state of research;Domestic Animal Endocrinology;2024-10

3. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists;Frontiers in Endocrinology;2024-07-24

4. GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology;Peptides;2024-07

5. Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes?;Journal of Endocrinology;2024-06-11